Spine BioPharma, Inc., a development stage company committed to non-opiate, non-surgical therapies for Degenerative Disc Disease (DDD), today announced the completion of enrollment of its U.S. Phase 3 ...

Merck Animal Health, a division of Merck & Co., Inc. (MRK), Tuesday announced the expansion of Nobivac NXT vaccine platform with the ...

Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced today the expansion of the newly ...

Novavax uses a protein-based vaccine strategy, which means people getting the vaccine receive a protein made by the virus ...

One major reason why it has been difficult to develop an effective HIV vaccine is that the virus mutates very rapidly, ...

Bavarian Nordic has received an order worth $63 million from the U.S. government to produce additional bulk product and the ...

Novavax, a protein-based vaccine, is an option for those who don't want or can't take an mRNA vaccine. Novavax may also be appealing to those wanting to experiment with the "mix-and-match ...

On Aug. 22, the U.S. Food and Drug Administration announced the approval of a new Novavax COVID vaccine, as well as updated ...

TriLink BioTechnologies and Alphazyme, both part of Maravai LifeSciences, have collaborated to launch CleanScribetm RNA Polymerase, a novel enzyme that reduces double-stranded RNA (dsRNA) in mRNA ...

Although Pfizer's and Moderna’s COVID-19 vaccines have been stealing the spotlight for years, some people are actively seeking out the lesser-known Novavax for their updated booster this fall.

“The idea that we would even question a policy that could possibly save the life of a student — this isn't vaccines,” she said. “These aren't masks. This is noninvasive. It is potentially ...